Mouse Anti-GRIA3 Recombinant Antibody (1D2) (CBMAB-G4892-LY)

Hu, M. J., Long, M., & Dai, R. J. (2022). Acetylation of H3K27 activated lncRNA NEAT1 and promoted hepatic lipid accumulation in non-alcoholic fatty liver disease via regulating miR-212-5p/GRIA3. Molecular and Cellular Biochemistry, 1-13.

Hamanaka, K., Miyoshi, K., Sun, J. H., Hamada, K., Komatsubara, T., Saida, K., ... & Matsumoto, N. (2022). Amelioration of a neurodevelopmental disorder by carbamazepine in a case having a gain-of-function GRIA3 variant. Human Genetics, 1-11.

Melnikova, A. M. E., Pijuan, J., Aparicio, J., Ramírez, A., Altisent-Huguet, A., Vilanova-Adell, A., ... & San Antonio-Arce, V. (2022). The p. Glu787Lys variant in the GRIA3 gene causes developmental and epileptic encephalopathy mimicking structural epilepsy in a female patient. European Journal of Medical Genetics, 65(3), 104442.

Rinaldi, B., Ge, Y. H., Freri, E., Tucci, A., Granata, T., Estienne, M., ... & Milani, D. (2022). Myoclonic status epilepticus and cerebellar hypoplasia associated with a novel variant in the GRIA3 gene. neurogenetics, 1-9.

Sun, J. H., Chen, J., Ayala Valenzuela, F. E., Brown, C., Masser-Frye, D., Jones, M., ... & Shi, Y. S. (2021). X-linked neonatal-onset epileptic encephalopathy associated with a gain-of-function variant p. R660T in GRIA3. PLoS Genetics, 17(6), e1009608.

Trivisano, M., Santarone, M. E., Micalizzi, A., Ferretti, A., Dentici, M. L., Novelli, A., ... & Specchio, N. (2020). GRIA3 missense mutation is cause of an x-linked developmental and epileptic encephalopathy. Seizure, 82, 1-6.

Piard, J., Béreau, M., XiangWei, W., Wirth, T., Amsallem, D., Buisson, L., ... & Yuan, H. (2020). The GRIA3 c. 2477G> A variant causes an exaggerated startle reflex, chorea, and multifocal myoclonus. Movement Disorders, 35(7), 1224-1232.

Wei, C., Zhang, R., Cai, Q., Gao, X., Tong, F., Dong, J., ... & Dong, X. (2019). MicroRNA-330-3p promotes brain metastasis and epithelial-mesenchymal transition via GRIA3 in non-small cell lung cancer. Aging (albany NY), 11(17), 6734.

Iamjan, S. A., Thanoi, S., Watiktinkorn, P., Reynolds, G. P., & Nudmamud-Thanoi, S. (2018). Genetic variation of GRIA3 gene is associated with vulnerability to methamphetamine dependence and its associated psychosis. Journal of Psychopharmacology, 32(3), 309-315.

Liu, Q., Sun, N. N., Wu, Z. Z., Fan, D. H., & Cao, M. Q. (2018). Chaihu-Shugan-San exerts an antidepressive effect by downregulating miR-124 and releasing inhibition of the MAPK14 and Gria3 signaling pathways. Neural regeneration research, 13(5), 837.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme-Linked Immunospot (ELISpot)
Proteogenomics
Other Protocols